Abstract:Background: Mesenchymal stromal cells (MSCs) have broad potential as a cell therapy including for the treatment of drug-resistant inflammatory conditions with abnormal T cell proliferation such as graft-versus-host disease (GVHD). Clinical success, however, has been complicated by the heterogeneity of culture-expanded MSCs as well as donor variability. Here, we devise culture conditions that promote expansion of MSCs with enhanced immunomodulatory functions both in vitro and in animal models of GVHD. Methods: Human bone marrow-derived MSCs were expanded at high-confluency (MSCHC) and low-confluency state (MSCLC). Their immunomodulatory properties were evaluated with in vitro co-culture assays based on suppression of activated T cell proliferation and secretion of pro-inflammatory cytokines from activated T cells. Metabolic state of these cells was determined, while RNA sequencing was performed to explore transcriptome of these MSCs. Ex vivo expanded MSCHC or MSCLC was injected into human peripheral blood mononuclear cells (PBMC)-induced GVHD mouse model to determine their in vivo therapeutic efficacy based on clinical grade scoring, human CD45+ blood count and histopathological examination. Results: As compared to MSCLC, MSCHC significantly reduced both the proliferation of anti-CD3/CD28-activated T cells and secretion of pro-inflammatory cytokines upon MSCHC co-culture across several donors even in the absence of cytokine priming. Mechanistically, metabolic analysis of MSCHC prior to co-culture with activated T cells showed increased glycolytic metabolism and lactate secretion compared to MSCLC, consistent with their ability to inhibit T cell proliferation. Transcriptome analysis further revealed differential expression of immunomodulatory genes including TRIM29, BPIFB4, MMP3 and SPP1 in MSCHC as well as enriched pathways including cytokine-cytokine receptor interactions, cell adhesion and PI3K-AKT signalling. Lastly, we demonstrate in a human PBMC-induced GVHD mouse model that delivery of MSCHC showed greater suppression of inflammation and improved outcomes compared to MSCLC and saline controls. Conclusion: Our study provides evidence that ex vivo expansion of MSCs at high confluency alters the metabolic and transcriptomic states of these cells. Importantly, this approach maximizes the production of MSCs with enhanced immunomodulatory functions without priming, thus providing a non-invasive and generalizable strategy for improving the use of MSCs for the treatment of inflammatory diseases.

Modulation of NLRP3 inflammasomes activation contributes to improved survival and function of mesenchymal stromal cell spheroids

3D spheroid culture synchronizes heterogeneous MSCs into an immunomodulatory phenotype with enhanced anti-inflammatory effects

Epigenetic changes of mesenchymal stem cells in three-dimensional (3D) spheroids.

Mesenchymal Stem Cells Attenuate Systemic Lupus Erythematosus by Inhibiting NLRP3 Inflammasome Activation Through Pim-1 Kinase.

CD73-Positive Cell Spheroid Transplantation Attenuates Colonic Atrophy

Efficacy of 3D Culture Priming is Maintained in Human Mesenchymal Stem Cells after Extensive Expansion of the Cells

Enhanced Immunosuppression of T Cells by Sustained Presentation of Bioactive Interferon-γ Within Three-Dimensional Mesenchymal Stem Cell Constructs

Modification of the inflammatory profile of mesenchymal stem cells using different culture conditions

Expansion of human bone marrow-derived mesenchymal stromal cells with enhanced immunomodulatory properties

Bone Marrow-Derived Mesenchymal Stem Cells in Three-Dimensional Culture Promote Neuronal Regeneration by Neurotrophic Protection and Immunomodulation.

Enhanced potent immunosuppression of intracellular adipose tissue-derived stem cell extract by priming with three-dimensional spheroid formation

Mesenchymal stem cells ameliorate inflammation and pyroptosis in diabetic cardiomyopathy via the miRNA-223-3p/NLRP3 pathway

3D spheroids of human placenta-derived mesenchymal stem cells attenuate spinal cord injury in mice

3D Spheroid Culture Enhances Survival and Therapeutic Capacities of MSCs Injected into Ischemic Kidney

Mesenchymal stem/stromal cells inhibit the NLRP3 inflammasome by decreasing mitochondrial reactive oxygen species

MSC Spheroids-Loaded Collagen Hydrogels Simultaneously Promote Neuronal Differentiation and Suppress Inflammatory Reaction Through PI3K-Akt Signaling Pathway.

Mesenchymal Stem Cells Attenuated PLGA-induced Inflammatory Responses by Inhibiting Host DC Maturation and Function.

Nestin Prevents Mesenchymal Stromal Cells from Apoptosis in LPS-induced Lung Injury Via Inhibition of Unfolded Protein Response Sensor IRE1α

Spontaneous Spheroids from Alveolar Bone-Derived Mesenchymal Stromal Cells Maintain Pluripotency of Stem Cells by Regulating Hypoxia-Inducible Factors

Novel Mesenchymal Stem Cell Spheroids with Enhanced Stem Cell Characteristics and Bone Regeneration Ability

Exosomal Mir-146A Contributes to the Enhanced Therapeutic Efficacy of Interleukin-1β-Primed Mesenchymal Stem Cells Against Sepsis.